Fig. 5From: Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathwayEndometrial fibrosis changes after BMSCs combined with estrogen treatment. A Western blot was used to detect the expression of fibrotic markers in endometrial tissues of each group. B Immunohistochemical staining to identify the expression of α-SMA in different treatment groups. C Immunohistochemical staini was used to detect p-Keratin expression in different treatment groups (× 40, scale bar = 200 μm; × 200, scale bar = 50 μm). *p < 0.05, **p < 0.01Back to article page